INVESTIGATION ALERT: Kaskela Law LLC Announces Stockholder Investigation of Take-Two Interactive Software, Inc. (TTWO) in Connection with Recent Merger Announcement
INVESTIGATION ALERT: Kaskela Law LLC Announces Stockholder Investigation of Take-Two Interactive Software, Inc. (TTWO) in Connection with Recent Merger Announcement
Investor protection firm Kaskela Law LLC announces that is investigating Take-Two Interactive Software, Inc. ("Take-Two") (NASDAQ: TTWO) on behalf of the company's stockholders.
On January 10, 2022, Take-Two announced that it had entered into a definitive agreement to acquire Zynga in a cash and stock transaction valued at $9.86 per Zynga share, with a total enterprise value of approximately $12.7 billion. According to the announcement, Take-Two is expected to issue between 50.3 million - 58.5 million shares of Take-Two stock to Zynga stockholders who are, as a result, expected to own between 29.6% - 32.8% of the combined company.
The investigation seeks to determine whether the members of Take-Two's Board of Directors violated the securities laws or breached their fiduciary duties to TTWO shareholders in connection with the proposed transaction, and whether Take-Two shareholders are being provided with all material information in connection with the proposed merger.
Take-Two shareholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 - 0750, or by email ([email protected]) or online at https://kaskelalaw.com/cases/take-two/, for additional information about this investigation and their legal rights and options.
Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.
CONTACT:
D. Seamus Kaskela, Esq. Adrienne Bell, Esq. KASKELA LAW LLC 18 Campus Blvd., Suite 100 Newtown Square, PA 19073 (484) 229 - 0750 (888) 715 - 1740 www.kaskelalaw.com
The fatal shooting of UnitedHealthcare CEO Brian Thompson on Dec. 4 prompted a national discussion on healthcare costs that included outcry from lawmakers and support for the shooting from frustrat...